AF
BIIB icon

Amalgamated Financial’s Biogen BIIB Stock Holding History

Amalgamated Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$7.76M Buy
+36,865
New +$8.02M 0.06% 276

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Amalgamated Financial's BIIB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Biogen (BIIB) in Q1 2022: 36,865 shares worth $7.76M. The stake represents 0.06% of the portfolio and ranks #276 among its holdings.

953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Amalgamated Financial held 36,865 shares of Biogen worth $7.76M as of Q1 2022.
  • Biogen was a new Amalgamated Financial position in Q1 2022.
  • Biogen made up 0.06% of Amalgamated Financial's portfolio in Q1 2022, its #276 holding.
  • 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.